<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.4 20190208//EN"
       "JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.4" xml:lang="en">
 <front>
  <journal-meta>
   <journal-id journal-id-type="publisher-id">Acta biomedica scientifica</journal-id>
   <journal-title-group>
    <journal-title xml:lang="en">Acta biomedica scientifica</journal-title>
    <trans-title-group xml:lang="ru">
     <trans-title>Acta biomedica scientifica</trans-title>
    </trans-title-group>
   </journal-title-group>
   <issn publication-format="print">2541-9420</issn>
   <issn publication-format="online">2587-9596</issn>
  </journal-meta>
  <article-meta>
   <article-id pub-id-type="publisher-id">14778</article-id>
   <article-id pub-id-type="doi">10.12737/23736</article-id>
   <article-categories>
    <subj-group subj-group-type="toc-heading" xml:lang="ru">
     <subject>Клиническая медицина</subject>
    </subj-group>
    <subj-group subj-group-type="toc-heading" xml:lang="en">
     <subject>Clinical Medicine</subject>
    </subj-group>
    <subj-group>
     <subject>Клиническая медицина</subject>
    </subj-group>
   </article-categories>
   <title-group>
    <article-title xml:lang="en">DEPENDENCE OF OUTCOMES OF HYPERTROPHIC SCARS LASER TREATMENT ON THE INITIAL REACTIVITY</article-title>
    <trans-title-group xml:lang="ru">
     <trans-title>ЗАВИСИМОСТЬ РЕЗУЛЬТАТА ЛАЗЕРНОГО ЛЕЧЕНИЯ ГИПЕРТРОФИЧЕСКИХ РУБЦОВ ОТ ИСХОДНОЙ РЕАКТИВНОСТИ ОРГАНИЗМА</trans-title>
    </trans-title-group>
   </title-group>
   <contrib-group content-type="authors">
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Кобец</surname>
       <given-names>Максим Владимирович</given-names>
      </name>
      <name xml:lang="en">
       <surname>Kobets</surname>
       <given-names>Maksim Владимирович</given-names>
      </name>
     </name-alternatives>
     <email>kobetsmv@gmail.com</email>
    </contrib>
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Васильева </surname>
       <given-names>Людмила  Сергеевна</given-names>
      </name>
      <name xml:lang="en">
       <surname>Vasilyeva</surname>
       <given-names>Lyudmila  Сергеевна</given-names>
      </name>
     </name-alternatives>
     <email> lsvirk@mail.ru</email>
    </contrib>
   </contrib-group>
   <pub-date publication-format="print" date-type="pub" iso-8601-date="2016-12-23T00:00:00+03:00">
    <day>23</day>
    <month>12</month>
    <year>2016</year>
   </pub-date>
   <pub-date publication-format="electronic" date-type="pub" iso-8601-date="2016-12-23T00:00:00+03:00">
    <day>23</day>
    <month>12</month>
    <year>2016</year>
   </pub-date>
   <volume>1</volume>
   <issue>6</issue>
   <fpage>60</fpage>
   <lpage>65</lpage>
   <self-uri xlink:href="https://zh-szf.ru/en/nauka/article/14778/view">https://zh-szf.ru/en/nauka/article/14778/view</self-uri>
   <abstract xml:lang="ru">
    <p>Цель – выявление взаимосвязи между реактивностью организма и результатом лечения гипертрофических рубцов. Установлено, что при положительном результате лечения у пациенток был ниже контрольного уровень СТГ (0,5±0,1мме/мл) и выше – уровни прогестерона (6,0±0,4нмоль/л) и ФСГ (6,7±0,5мме/мл); при отрицательном результате выше индекс атерогенности (2,6±0,2) и уровень СТГ (2,1±0,5), ниже – уровни кортизола (346,8±39нмоль/л), тестостерона (1,5±0,2мме/мл), IL-10 (3,89±1,6нг/мл) и антител к IFN-γ (0,206±0,05отн.ед.), IFN-α (0,385±0,02) и Fc-фрагментам (0,317±0,04) </p>
   </abstract>
   <trans-abstract xml:lang="en">
    <p>The purpose of the study was to identify the relationship between the initial state of the organism and the result of the treatment of hypertrophic scars. 38women of 16–35years of age were examined on the 5–7th days of the menstrual cycle, 16 of them had normotrophic scars and 22 – hypertrophic scars. The quality of scars, lipid profile, the concen-tration of thyrotropin, free fraction of thyroxine, growth hormone (GH), luteinizing and follicle stimulating hormone (FSH), cortisol, prolactin, estradiol, testosterone, progesterone , the concentration of TNF-α, IL-4, IL-6, IL-10, and the level of autoantibodies to DNA, IFN-α , IFN-γ, b2-glycoprotein, Fc-fragments, collagen-2 were determined. Further on the laser treatment was performed: the scar surface was treated by multiple perforations under local anesthesia. Treatment outcome was assessed in 3months by the clinical characteristics of the scar. It was found that in 10women hypertrophic scars reformed in normotrophic scars after the treatment, and 12women still had hypertrophic scars. Patients with a positive result of treatment had a low concentration of GH (0.5±0.1) and high concentrations of proges-terone (6.0±0.4) and FSH (6.7±0.5 in the follicular phase of the cycle). The negative result of the treatment obtained in patients with significant shifts reactivity indicators: high atherogenic index (2.6±0.2) and the level of GH (2.1±0.5), low levels of cortisol (346.8±39), testosterone (1.5±0.2), IL-10 (3.89±1.6) and antibodies to IFN-γ (0.206±0.05), IFN-α (0.385±0.02), Fc-fragments (0.317±0.04).</p>
   </trans-abstract>
   <kwd-group xml:lang="ru">
    <kwd>лечение гипертрофических рубцов</kwd>
    <kwd>реактивность организма</kwd>
    <kwd>патогенез гипертрофиче-ских рубцов</kwd>
   </kwd-group>
   <kwd-group xml:lang="en">
    <kwd>treatment of hypertrophic scars</kwd>
    <kwd>reactivity</kwd>
    <kwd>pathogenesis of hypertrophic scars</kwd>
   </kwd-group>
  </article-meta>
 </front>
 <body>
  <p></p>
 </body>
 <back>
  <ref-list>
   <ref id="B1">
    <label>1.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">ПоляковЛ.М., СуменковаД.В., КнязевР.А. Ана-лиз взаимодействия липопротеинов и стероидных гормонов //Биомедицинская химия. - 2011. - Т.57, Вып.3. - С.308-313.</mixed-citation>
     <mixed-citation xml:lang="en">PolyakovLM, SumenkovaDV, KnyazevRA (2011).Analysis of the interaction of lipoproteins and steroid hormones [Analiz vzaimodeystviya lipoproteinov i steroidnykh gormonov]. Biomeditsinskaya khimiya, 57(3), 308-313.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B2">
    <label>2.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">ТенчуринаТ.Г. Значение половых стероидов и ангиогенных факторов роста в профилактике ослож-нений рубцевания после косметических операций //Экспериментальная и клиническая дерматокос-метология. - 2005 - No4. - С.17-20</mixed-citation>
     <mixed-citation xml:lang="en">TenchurinaTG (2005). Significance of sex steroids and angiogenic growth factors in the prevention of scarring complications after cosmetic surgery [Znachenie polovykh steroidov i angiogennykh faktorov rosta v profilaktike os-lozhneniy rubtsevaniya posle kosmeticheskikh operatsiy]. Eksperimental’naya i klinicheskaya dermatokosmetologiya, (4), 17-20</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B3">
    <label>3.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">ШварцЯ.Ш. Действие холестерина и агонистов ядерных гормональных рецепторов на продукцию трансформирующего фактора роста-бета в макро-фагах //Бюллетень экспериментальной биологии и медицины. - 2009. - No9. - С.294-297.</mixed-citation>
     <mixed-citation xml:lang="en">SchwartzYS (2009). Effects of cholesterol and nuclear hormone receptor agonists in the production of trans-forming growth factor-beta in macrophages [Deystvie kholesterina i agonistov yadernykh gormonal’nykh ret-septorov na produktsiyu transformiruyushchego faktora rosta-beta v makrofagakh]. Byulleten’ eksperimental’noy biologii i meditsiny, (9), 294-297.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B4">
    <label>4.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru"></mixed-citation>
     <mixed-citation xml:lang="en">AshcroftGS, DodsworthJ, van BoxtelE (1997). Estrogen accelerates cutaneous wound healing associated with an increase in TGF-beta1 levels. Nat Med., 3(11), 1209-1215.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B5">
    <label>5.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru"></mixed-citation>
     <mixed-citation xml:lang="en">GilliverSC (2006). Androgens modulate the inflammatory response during acute wound healing. J.CellSci., 119(4), 722-732</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B6">
    <label>6.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru"></mixed-citation>
     <mixed-citation xml:lang="en">FruchtmanS, SimmonsJG, MichayliraCZ (2005). Suppressor of cytokine signaling-2 modulates the fibrogenic actions of GH and IGF-I in intestinal mesenchymal cells. Am.J..Physiol. Gastrointest. Liver Physiol., 289(2), 342-350</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B7">
    <label>7.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru"></mixed-citation>
     <mixed-citation xml:lang="en">HuZC, TangB, GuoD, ZhangJ, LiangYY, MaD,ZhuJY (2014). Expression of insulin-like growth factor-1 receptor in keloid and hypertrophic scar. Clin. Exp. Dermatol.,39(7), 822-828.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B8">
    <label>8.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru"></mixed-citation>
     <mixed-citation xml:lang="en">KandaN, WatanabeS (2005) Regulatory roles of sex hormones in cutaneous biology and immunology. J.Dermatol. Sci., 38(1), 1-7</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B9">
    <label>9.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru"></mixed-citation>
     <mixed-citation xml:lang="en">KaramoutiM, KolliaP, KallitsarisA, Vamvakopou-losN, KolliosG, MessinisIE (2008) Growth hormone, insulin-like growth factor I, and leptin interaction in hu-man cultured lutein granulosa cells steroidogenesis. Fertil. Steril., 90(4), 1444-1450</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B10">
    <label>10.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru"></mixed-citation>
     <mixed-citation xml:lang="en">LawrenceJW (2012). Epidemiology and impact of scarring after burn injury: a systematic review of the literature. J.Burn. Care Res., 33(1), 136-146.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B11">
    <label>11.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru"></mixed-citation>
     <mixed-citation xml:lang="en">SchmidtM, RennerC, LöfflerG (1998) Proges-terone inhibits glucocorticoid-dependent aromatase induction in human adipose fibroblasts. J.Endocrinol.,158(3), 401-407.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B12">
    <label>12.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru"></mixed-citation>
     <mixed-citation xml:lang="en">TaketaniT, YamagataY, TakasakiA, MatsuokaA, TamuraH, SuginoN (2008) Effects of growth hormone and insulin-like growth factor 1 on progesterone production in human luteinized granulosa cells. Fertil. Steril., 90(3), 744-748.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B13">
    <label>13.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru"></mixed-citation>
     <mixed-citation xml:lang="en">Van VugtHH (2008). Somatostatin in the rat periventricular nucleus: sex differences and effect of gonadal steroids. Exp.Brain.Res., 188(4), 483-491.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B14">
    <label>14.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru"></mixed-citation>
     <mixed-citation xml:lang="en">WangJ, JiaoH, StewartTL, ShankowskyHA,ScottPG, TredgetEE (2007). Increased TGF-beta-producing CD4+ T lymphocytes in postburn patients and their potential interaction with dermal fibroblasts in hypertrophic scarring. Wound Repair Regen., 15(4), 530-539.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B15">
    <label>15.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru"></mixed-citation>
     <mixed-citation xml:lang="en">ZhuZ, DingJ, ShankowskyHA, TredgetEE (2013).The molecular mechanism of hypertrophic scar. J.Cell. Commun. Signal., 7(4), 239-252.</mixed-citation>
    </citation-alternatives>
   </ref>
  </ref-list>
 </back>
</article>
